• If you are wondering whether Veeva Systems is starting to look interesting at its current share price, this article will walk you through what that price might actually imply about value.
• The stock last closed at US$176.82, after share price returns of a 5.4% decline over 7 days, 20.4% decline over 30 days, 19.4% decline year to date, 24.1% decline over 1 year, 4.2% gain over 3 years and 39.2% decline over 5 years.
• Recent coverage has focused on Veeva Systems as a key software provider to life sciences and healthcare companies, with investors paying close attention to how sector demand and client spending plans may affect its long term growth profile. Commentators have also highlighted ongoing interest in how subscription based revenue models in healthcare software are being valued relative to companies in other tech focused sectors. This helps frame the current share price moves.
• Veeva Systems currently has a valuation score of 4/6. Next we will break down what that means across different valuation methods before finishing with a broader way to think about what the market is pricing in.

Approach 1: Veeva Systems Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a company might be worth today by taking its projected future cash flows and discounting them back to a present value.

For Veeva Systems, the model uses a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is about $1.35b. Analysts provide free cash flow estimates for the next few years. Simply Wall St then extends those projections further out, reaching an estimated free cash flow of around $2.46b in 2031, with incremental estimates through 2035 included in the model.

Bringing all those projected cash flows back to today, the DCF model arrives at an estimated intrinsic value of about $261.53 per share. Compared with the recent share price of $176.82, this implies the stock is about 32.4% below that DCF estimate, which indicates that Veeva Systems is trading at a discount to this cash flow based valuation.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Veeva Systems is undervalued by 32.4%. Track this in your watchlist or portfolio, or discover 56 more high quality undervalued stocks.

Approach 2: Veeva Systems Price vs Earnings

For profitable companies like Veeva Systems, the P/E ratio is a common way to think about value because it links what you pay for each share to the earnings that each share generates. A higher or lower P/E often reflects what the market is factoring in for future growth, quality and risk, so there is no single “right” number that applies to every business.

Veeva Systems currently trades on a P/E of 33.78x. That sits above the Healthcare Services industry average of 29.07x, but below the peer group average of 44.89x. On their own, those comparisons only tell you how the market is pricing Veeva Systems relative to broad groups, which may have very different growth profiles, margins, sizes and risk levels.

Simply Wall St’s Fair Ratio for Veeva Systems is 30.59x, which is its estimate of what a “normal” P/E might look like for this company given factors such as earnings growth, profit margins, industry, market cap and risk. This tailored yardstick can be more helpful than a simple industry or peer comparison because it is built around company specific characteristics. With the current P/E of 33.78x above the Fair Ratio of 30.59x, Veeva Systems screens as slightly expensive on this metric.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 23 top founder-led companies.

Upgrade Your Decision Making: Choose your Veeva Systems Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, which are simply your story about a company linked to numbers like fair value, and your assumptions for future revenue, earnings and margins.

On Simply Wall St’s Community page, Narratives help you connect Veeva Systems’ business story to a financial forecast and then to a fair value, so you can compare that fair value to the current share price and decide for yourself whether the gap between the two is large enough to act on.

Narratives are kept up to date as new news, earnings or guidance arrive, so your view is not static, and you can quickly see how fresh information changes the gap between price and value.

For example, one Veeva Systems Narrative currently anchors on a fair value of about US$232.80 while another uses a higher fair value of about US$380.00. This shows how two investors can look at the same company, plug in different expectations for revenue growth, margins and future P/E, and reach very different conclusions about whether the current share price looks high or low to them.

Do you think there's more to the story for Veeva Systems? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.